Cidara Therapeutics (CDTX) Prices 14.84M Share Offering at $1.55/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
After-Hours Stock Movers 10/07: (MNTV) (QDEL) Higher; (ALLO) (AGRX) (CDTX) Lower (more...)
October 7, 2021 6:00 PM EDTAfter-Hours Stock Movers:
Allogene Therapeutics, Inc. (Nasdaq: ALLO) 33% LOWER; reported that following a report of a chromosomal abnormality in ALLO-501A CAR T cells in a patient treated in the ALPHA2 study, the U.S. Food and Drug Administration (FDA) has placed a hold on the Companys AlloCAR... More
Cidara Therapeutics (CDTX) Commences Concurrent Public Offerings of Common Stock and Preferred Stock
October 7, 2021 4:01 PM EDTCidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed to improve the standard of care for patients facing serious diseases, today announced that it has commenced concurrent but separate underwritten public offerings of its common stock and its Series X... More
